Status Topic selection
Technology type Medicine
Decision Not selected
Reason for decision Not eligible for Health Technology Evaluation guidance
Further information Decision makers have concluded that the clear rationale to not evaluate this product is due to a clinical guideline (CG61) being available that already which includes a recommendation for the use of Linaclotide acetate for treating Chronic idiopathic constipation. Therefore, a TA would not add any further value.
ID number 12005

Project Team

Project lead Danielle Lees

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
10 September 2024 Topic selection

For further information on how we select topics for development, please see our page about topic selection